Nightingale Health

Building sustainable healthcare

Health Check

The most advanced health check for the health industry.

Remote Health Check

The most advanced remote health check for the health industry.

Technology

Innovation that doesn’t disrupt anything but changes everything.

Mission

Building sustainable healthcare and reducing health inequalities.

For research

The gold standard ’omics for the research community.

Latest news

Stock exchange release

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Apr 23, 2025

Press releases

Nightingale Health’s laboratory implementation in the United States progresses as planned – opens first to medical research customers in Summer 2025

Apr 10, 2025

Stock exchange release

Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US

Mar 21, 2025

Stock exchange release

Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025

Mar 18, 2025

Stock exchange release

The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus

Mar 17, 2025

Stock exchange release

Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US

Mar 17, 2025

Subscribe to our newsletter!

Nightingale Health

Building sustainable healthcare

The most advanced health check for the health industry.

The most advanced remote health check for the health industry.

For healthcare providers

For insurance

For governments and health systems

For consumer health

For telehealth

For medical research

Technology

Mission

For research

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Nightingale Health’s laboratory implementation in the United States progresses as planned – opens first to medical research customers in Summer 2025

Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US

Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025

The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus

Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US

Subscribe to our newsletter!